Akari Therapeutics (NASDAQ:AKTX) Coverage Initiated by Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 1.9 % Shares of Akari Therapeutics stock opened at $1.10 on Tuesday. The business has a 50-day […]
Equities research analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a report issued on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Akari Therapeutics Trading Up 1.9 % Shares of Akari Therapeutics stock opened at $1.10 on Tuesday. The business has a 50-day […]
